rabeprazole

Rabeprazole (LY307640) is an H+ K+-ATPase inhibitor that inhibits cell proliferation in gastric epithelial cells by targeting STAT3-mediated glycolysis and can be used in the study of gastric ulcers.

Rabeprazole Sulfide (Rabeprazole Related Compound E) is an antiulcer drug in the class of proton pump inhibitors.

Rabeprazole sodium (Habeprazole Sodium) is a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. The drug inhibits H(+)-K(+)-exchanging ATPase which is found in gastric parietal cells.

Rabeprazole sulfone, a metabolite of the proton pump inhibitor rabeprazole, is produced via the cytochrome P450 (CYP) isoform CYP3A. Additionally, it has been identified as an impurity in bulk rabeprazole preparations.